CDT Equity Inc CDT
Trading Information
- Previous Close Price
- $0.99
- Day Range
- $0.85–0.97
- 52-Week Range
- $0.85–44,450.00
- Bid/Ask
- $0.89 / $0.93
- Shares Outstanding
- 40,541.00
- Market Cap
- $707,297.09
- Volume/Avg
- 340,404 / 154,769
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 4
- Website
- https://www.cdtequity.com
Valuation
|
Metric
|
CDT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.00 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CDT
|
|---|---|
Quick Ratio | 0.04 |
Current Ratio | 0.13 |
Interest Coverage | −243.49 |
Quick Ratio
CDT
Profitability
|
Metric
|
CDT
|
|---|---|
Return on Assets (Normalized) | −60.64% |
Return on Equity (Normalized) | −80.01% |
Return on Invested Capital (Normalized) | −77.20% |
Return on Assets
CDT
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|?Wq$xd | LOCK|?#CD | $128B | |||
| Moderna Inc
MRNA
| LOCK|$<k^^YW | LOCK|>y | $76B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|C##lfKP | LOCK|@sJb | $76B | |||
| argenx SE ADR
ARGX
| LOCK|<#^@glQ | LOCK|%HH | $57B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|X$^$XP# | LOCK|HLY | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|&KLrCT | LOCK|sx$^m | $29B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|<K^bVn$ | LOCK|gXhbb | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|%?nMp>> | LOCK|r# | $24B | |||
| Incyte Corp
INCY
| LOCK|dw&jlF& | LOCK|?y | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|x>m!kY | LOCK|<f@ | $15B |
United States